Our leadership team is united by an unwavering commitment to creating value through the development of innovative new therapies to improve the treatment of cancer. Bringing together years of industry experience, our dedicated team shares the same vision to create therapies that make a meaningful difference in the lives of patients.
Michael M. Morrissey, Ph.D.
President and Chief Executive Officer
Jeffrey J. Hessekiel, J.D.
Executive Vice President and General Counsel
Peter Lamb, Ph.D.
Executive Vice President, Scientific Strategy and Chief Scientific Officer
Gisela M. Schwab, M.D.
President, Product Development and Medical Affairs and Chief Medical Officer
Christopher J. Senner
Executive Vice President and Chief Financial Officer